Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
US Department of Justice
Boehringer Ingelheim

Generated: December 17, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

When do Claritin Hives Relief patents expire, and when can generic versions of Claritin Hives Relief launch?

Claritin Hives Relief is a drug marketed by Bayer Healthcare Llc and is included in three NDAs.

The generic ingredient in CLARITIN HIVES RELIEF is loratadine. There are thirty-nine drug master file entries for this compound. One hundred and thirty-one suppliers are listed for this compound. Additional details are available on the loratadine profile page.
Drug patent expirations by year for CLARITIN HIVES RELIEF

Medical Subject Heading (MeSH) Categories for CLARITIN HIVES RELIEF

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare LlcCLARITIN HIVES RELIEFloratadineSYRUP;ORAL020641-003Nov 19, 2003DISCNYesNo► Subscribe► Subscribe► Subscribe
Bayer Healthcare LlcCLARITIN HIVES RELIEFloratadineTABLET;ORAL019658-003Nov 19, 2003OTCYesYes► Subscribe► Subscribe► Subscribe
Bayer Healthcare LlcCLARITIN HIVES RELIEF REDITABloratadineTABLET, ORALLY DISINTEGRATING;ORAL020704-003Nov 19, 2003OTCYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Express Scripts
Farmers Insurance
Cantor Fitzgerald
Queensland Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: